Pharma Industrial India Magazine - July - August 2024

PHARMA INDUSTRIALINDIA · JUL-AUG 24 21 INTERVIEW ing process and even account for the decomposition of drugs. Overall, compressed air laden with moisture upon coming into contact with the drugs can compromise their medicinal value. Moving ahead, the destructive effect of moisture can even be seen during the spray coating of the tablets. In the process, moisture comes with the ability to change the colour, smell, and taste of the medicines. It is also responsible for giving rise to blisters on the tablets and, at times, can also lead to the breakage of the tablets as well. Performing uneven coating, inferior-quality tablets are manufactured as end products. All the factors together tend to trigger enzymatic, microbiological and biochemical deterioration of pharmaceutical products. Here, the Delair products come in handy for efficiently remov - ing the moisture from the compressed air. Consequently, it also contributes to the efficacy of the entire manufacturing process and, in turn, is responsible for the production of high-quality medicines. Conducting all the pneumatic processes under high pressure in a completely dry state aids in passing the quality checks by meeting the highest industry standards. Q Explain the role of pneumatic control systems in pharma- ceutical manufacturing processes and how does Delair’s technology help in reducing maintenance costs for pneumatic machines and tools? Deepesh Upadhyay: Pneumatic control systems are very cru- cial for pharmaceutical manufacturing as they take care of pre- cise, reliable, and safe operation of the various equipment and systems. They come in handy for regulating the process by ex- ercising control over the flow of liquids, gases, and powders to retain the quality and consistency of the products. Additionally, the automated capabilities help in ensuring accuracy and con- sistency of quantities throughout the dosing, filling, and pack - aging processes. It is also sought for maintaining the sterility of various operations that prevent contamination of the products. However, the perils of moisture in compressed air extend even to pneumatic tools and machines, accounting for their malfunctioning. Moisture inherently causes corrosion in pipes, pneumatic operated cylinders, zig & fixtures, and other com - ponents. Likewise, it also gives rise to the sluggish and incon- sistent functioning of pneumatic valves and cylinders. The problem is further exacerbated during the cold weather when freezing issues become common in the equipment. Having a damaging effect, ultimately, moisture can incur high mainte- nance costs for the company. As Delair systems ensure the purity & dryness of compressed air that is devoid of any form of moisture or contaminants, this helps in avoiding any instances of damage to the pneumatic systems. They resist the corrosion of systems and also main- tain the optimal performance of the systems. Q How does Delair’s compressed air technology align with GMP (Good Manufacturing Practice) standards? Deepesh Upadhyay: Adhering to the quality standards of ISO 8573-1:2010 Class 1, Delair plays a vital role in supporting GMP practices mandated by government regulations. These guidelines aim to preserve the authenticity and excellence of the pharmaceutical industry by ensuring the production of safe, effective, and high-quality drugs. Delair’s compressed air dryers, utilizing desiccant-based drying technology, treat com- pressed air to achieve dew point temperatures ranging from -40°C to as low as -70°C. Air dried to a dew point of -70°C is considered 100% dry and meets the highest standards for use in healthcare settings, including as breathable air in hospitals. This technology supports strict hygiene standards in compli- ance with FDA recommendations, ensuring the quality and safety of pharmaceutical production. Q What innovations has Delair introduced to improve the ef- ficiency and reliability of compressed air systems in the pharmaceutical industry? Deepesh Upadhyay: Delair is at the forefront of integrating ad- vanced technologies to enhance the efficiency and reliability of compressed air systems. By seamlessly incorporating digitiza- tion and automation, Delair supports state-of-the-art pharma- ceutical manufacturing. Its advanced systems enable precise management of energy-saving drying cycles, leveraging the Dew Point Based Dependence System (DPDS) for purge opti- mization. This technology minimizes purge losses by extend- ing regeneration cycle times, contributing to significant energy savings. Delair’s systems also feature advanced filtration with automatic condensate management and differential pressure gauges, ensuring smooth operation. These systems efficiently remove dust, oil aerosols, and vapors, maintaining high air pu- rity and reliability.